UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 290

Sortiert nach

Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

Journal of clinical oncology, 2017-10, Vol.35 (30), p.3484-3515

2017

Link zum Volltext

Verfügbarkeit prüfen

Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

Journal of clinical oncology, 2015-10, Vol.33 (30), p.3488-3515

2015

Link zum Volltext

Verfügbarkeit prüfen

Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update

Journal of clinical oncology, 2020-05, Vol.38 (14), p.1608-1632

2020

Link zum Volltext

Verfügbarkeit prüfen

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events

Journal for immunotherapy of cancer, 2021-06, Vol.9 (6), p.e002435

2021

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non-Small-Cell Lung Cancer

Journal of clinical oncology, 2020-03, Vol.38 (7), p.706-714

2020

Link zum Volltext

Verfügbarkeit prüfen

Gefitinib Versus Placebo in Completely Resected Non–Small-Cell Lung Cancer: Results of the NCIC CTG BR19 Study

Journal of clinical oncology, 2013-09, Vol.31 (27), p.3320-3326

2013

Link zum Volltext

Verfügbarkeit prüfen

Fatty acid transport protein 2 reprograms neutrophils in cancer

Nature (London), 2019-05, Vol.569 (7754), p.73-78

2019

Link zum Volltext

Verfügbarkeit prüfen

CD45 Phosphatase Inhibits STAT3 Transcription Factor Activity in Myeloid Cells and Promotes Tumor-Associated Macrophage Differentiation

Immunity (Cambridge, Mass.), 2016-02, Vol.44 (2), p.303-315

2016

Link zum Volltext

Verfügbarkeit prüfen

Chemotherapy With or Without Maintenance Sunitinib for Untreated Extensive-Stage Small-Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase II Study-CALGB 30504 (Alliance)

Journal of clinical oncology, 2015-05, Vol.33 (15), p.1660-1665

2015

Link zum Volltext

Verfügbarkeit prüfen

Safety and Immunogenicity of the PRAME Cancer Immunotherapeutic in Patients with Resected Non–Small Cell Lung Cancer: A Phase I Dose Escalation Study

Journal of thoracic oncology, 2016-12, Vol.11 (12), p.2208-2217

2016

Link zum Volltext

Verfügbarkeit prüfen

Linking climate change and species invasion: an illustration using insect herbivores

Global change biology, 2007-08, Vol.13 (8), p.1605-1615

2007

Link zum Volltext

Verfügbarkeit prüfen

Short Communication: Interim toxicity analysis for patients with limited stage small cell lung cancer (LSCLC) treated on CALGB 30610 (Alliance) / RTOG 0538

Lung cancer (Amsterdam, Netherlands), 2021-06, Vol.156, p.68-71

2021

Link zum Volltext

Verfügbarkeit prüfen

Immune suppressive activity of myeloid-derived suppressor cells in cancer requires inactivation of the type I interferon pathway

Nature communications, 2021-03, Vol.12 (1), p.1717-1717, Article 1717

2021

Link zum Volltext

Verfügbarkeit prüfen

American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2009-12, Vol.27 (36), p.6251-6266

2009

Link zum Volltext

Verfügbarkeit prüfen

Distinct Populations of Immune-Suppressive Macrophages Differentiate from Monocytic Myeloid-Derived Suppressor Cells in Cancer

Cell reports (Cambridge), 2020-12, Vol.33 (13), p.108571-108571, Article 108571

2020

Link zum Volltext

Verfügbarkeit prüfen

Identification of monocyte-like precursors of granulocytes in cancer as a mechanism for accumulation of PMN-MDSCs

The Journal of experimental medicine, 2019-09, Vol.216 (9), p.2150-2169

2019

Link zum Volltext

Verfügbarkeit prüfen

Clinical cancer advances 2015: Annual report on progress against cancer from the American Society of Clinical Oncology

Journal of clinical oncology, 2015-03, Vol.33 (7), p.786-809

2015

Link zum Volltext

Verfügbarkeit prüfen

Precision Medicine in Lung Cancer Treatment

Surgical oncology clinics of North America, 2020-01, Vol.29 (1), p.15-21

2020

Link zum Volltext

Verfügbarkeit prüfen

2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2011-10, Vol.29 (28), p.3825-3831

2011

Link zum Volltext

Verfügbarkeit prüfen

Randomized Phase II Study of Carboplatin and Etoposide With or Without the bcl-2 Antisense Oligonucleotide Oblimersen for Extensive-Stage Small-Cell Lung Cancer: CALGB 30103

Journal of clinical oncology, 2008-02, Vol.26 (6), p.870-876

2008

Link zum Volltext

Verfügbarkeit prüfen

Randomized Phase II Trial of Induction Chemotherapy Followed by Concurrent Chemotherapy and Dose-Escalated Thoracic Conformal Radiotherapy (74 Gy) in Stage III Non–Small-Cell Lung Cancer: CALGB 30105

Journal of clinical oncology, 2008-05, Vol.26 (15), p.2457-2463

2008

Link zum Volltext

Verfügbarkeit prüfen

Clinical Cancer Advances 2013: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology

Journal of clinical oncology, 2014-01, Vol.32 (2), p.129-160

2014

Link zum Volltext

Verfügbarkeit prüfen

Eicosanoid Modulation in Advanced Lung Cancer: Cyclooxygenase-2 Expression Is a Positive Predictive Factor for Celecoxib + Chemotherapy—Cancer and Leukemia Group B Trial 30203

Journal of clinical oncology, 2008-02, Vol.26 (6), p.848-855

2008

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 290

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(251)
Mit Volltextzugriff
(239)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(153)
Life Sciences & Biomedicine
(141)
Humans
(122)
Oncology
(67)
Female
(59)
Male
(56)
Middle Aged
(45)
Aged
(44)
Adult
(42)
Lung Neoplasms - Drug Therapy
(39)
Biological And Medical Sciences
(38)
Lung Neoplasms - Pathology
(31)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(29)
Aged, 80 And Over
(26)
Medical Sciences
(24)
Carcinoma, Non-Small-Cell Lung - Pathology
(23)
Neoplasm Staging
(23)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(20)
Neurosciences & Neurology
(20)
Respiratory System
(19)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events

Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non-Small-Cell Lung Cancer

Gefitinib Versus Placebo in Completely Resected Non–Small-Cell Lung Cancer: Results of the NCIC CTG BR19 Study

Fatty acid transport protein 2 reprograms neutrophils in cancer

Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study

CD45 Phosphatase Inhibits STAT3 Transcription Factor Activity in Myeloid Cells and Promotes Tumor-Associated Macrophage Differentiation

Chemotherapy With or Without Maintenance Sunitinib for Untreated Extensive-Stage Small-Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase II Study-CALGB 30504 (Alliance)

Safety and Immunogenicity of the PRAME Cancer Immunotherapeutic in Patients with Resected Non–Small Cell Lung Cancer: A Phase I Dose Escalation Study

Linking climate change and species invasion: an illustration using insect herbivores

Short Communication: Interim toxicity analysis for patients with limited stage small cell lung cancer (LSCLC) treated on CALGB 30610 (Alliance) / RTOG 0538

Immune suppressive activity of myeloid-derived suppressor cells in cancer requires inactivation of the type I interferon pathway

American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer

Distinct Populations of Immune-Suppressive Macrophages Differentiate from Monocytic Myeloid-Derived Suppressor Cells in Cancer

Identification of monocyte-like precursors of granulocytes in cancer as a mechanism for accumulation of PMN-MDSCs

Clinical cancer advances 2015: Annual report on progress against cancer from the American Society of Clinical Oncology

Therapy of Small Cell Lung Cancer (SCLC) with a Topoisomerase-I-inhibiting Antibody-Drug Conjugate (ADC) Targeting Trop-2, Sacituzumab Govitecan

Precision Medicine in Lung Cancer Treatment

2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer

Randomized Phase II Study of Carboplatin and Etoposide With or Without the bcl-2 Antisense Oligonucleotide Oblimersen for Extensive-Stage Small-Cell Lung Cancer: CALGB 30103

Randomized Phase II Trial of Induction Chemotherapy Followed by Concurrent Chemotherapy and Dose-Escalated Thoracic Conformal Radiotherapy (74 Gy) in Stage III Non–Small-Cell Lung Cancer: CALGB 30105

Clinical Cancer Advances 2013: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology

Eicosanoid Modulation in Advanced Lung Cancer: Cyclooxygenase-2 Expression Is a Positive Predictive Factor for Celecoxib + Chemotherapy—Cancer and Leukemia Group B Trial 30203

Suchergebnisse filtern